The Royal Melbourne Hospital Department of Diabetes and Endocrinology is strongly committed to improvement through research and innovation. We have shown that ongoing research and quality initiatives lead to tangible improvements in clinical outcomes.
About our research
Our clinical and laboratory research activities integrate basic, translational and health delivery clinical research with clinical services and education of patients.
Through this commitment we have developed an infrastructure and support mechanisms for early career and established investigators. Our clinical and laboratory research activities integrate basic, translational and health delivery clinical research with clinical services and education of patients. Through this commitment we have developed an infrastructure and support mechanisms for early career and established investigators. A strength of our research program is that we are able to integrate basic science, translational science, and clinical trials to achieve improved health outcomes for patients with endocrine disease.
We are committed to our research program in the three major endocrine pillars of diabetes, bone mineral and pituitary disorders. Specific areas of interest include:
- Prevention, prediction and treatment of type 1 diabetes
- Medical device technologies with insulin pumps and glucose sensors
- Precision diagnostics and therapeutics for type 2 diabetes and other forms of diabetes
- Diabetes complications
- Inpatient diabetes care
- Bone and mineral disorders, including osteoporosis
- Pituitary disorders
Current research studies
We are currently undertaking research studies for:
- Stoic-D Type 1
Find out more about current clinical trials.
- Extensive type 1 diabetes autoimmunity screening programs
- Largest cluster-randomised trial in the world of hospital diabetes in non-critical care
- Design of peripheral quantitative CT and data analysis to become a valuable tool in the evaluation of bone fragility
We work in close partnership with:
- Parkville Biomedical Precinct, including University of Melbourne and Walter & Eliza Hall Institute of Medical Research
- Endocrine Society of Australia
- Diabetes Australia
- Australian Diabetes Society
A storm off the charts: a case of thyroid storm due to thyrotoxicosis factitia
Giang, NA; Lafontaine, N; Kyi, M
(2021), Intern. Med. J., 806-807
Advances in Type 1 Diabetes Prediction Using Islet Autoantibodies: Beyond a Simple Count
So, M; Speake, C; Steck, AK; Lundgren, M; Colman, PG; Palmer, JP; Herold, KC; Greenbaum, CJ
(2021), Endocr. Rev., 584-604
Approach to Interpreting Common Laboratory Pathology Tests in Transgender Individuals
Cheung, AS; Lim, HY; Cook, T; Zwickl, S; Ginger, A; Chiang, C; Zajac, JD
(2021), J. Clin. Endocrinol. Metab., 893-901
Latest news & events
Researchers from the Royal Melbourne Hospital (RMH) have shown that a blood test for early diagnosis of type 1 diabetes can prevent serious illness and hospitalisation in children. The innovative test is a finger prick sample that is collected in the home and mailed to the lab.
A national diabetes research centre initiative involving the Royal Melbourne Hospital has been funded through a significant Australian Government grant.
Researchers at the Royal Melbourne Hospital (RMH) have been funded $1.8 million in the latest round of National Health and Medical Research Council’s (NHMRC) Investigator Grants.
Researchers from Melbourne have led a global collaboration to develop a simplified blood test that increases the overall screening efficiency for type 1 diabetes.
More than 4 in 5 people with diabetes have experienced stigma while living with their condition.
Lucy Lee is the first person to take part in the BANDIT clinical trial, which began at the Royal Melbourne Hospital this month.
The RMH Endocrinologist Dr Rahul Barmanray has won the 2020 Australasian Diabetes Society President’s Clinical Young Investigator of the Year Award.
Here's a story from Raj, a person with diabetes.
We need clinical trials to prove that new treatments are safe and effective for people to use. They are essential to the discovery of new medications and devices, neither of which can be approved for use in Australia without clinical trials.